New York, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Kenneth Research has published a detailed market report on ‘Global Urinalysis Test Market’ for the forecast period, i.e. 2023 – 2033, which includes the following factors:
- Market growth over the forecast period
- Detailed regional synopsis
- Market segmentation
- Growth drivers
- Profiling of key market players
Global Urinalysis Test Market Size:
The global urinalysis test market is estimated to garner a notable by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated significant revenue in the year 2022. The growth of the market can majorly be attributed to the increasing incidence of death rates followed by a rise in the number of diabetes patients. According to the World Health Organization, between 2000 and 2019, there was a 3 percent increase in diabetes mortality rates by age. In 2019, diabetes and kidney disease due to diabetes caused an estimated 2 million deaths. The global market is further expected to be propelled by factors, such as surging chronic kidney diseases, rising geriatric population, surge in liver disease cases, and increasing pregnancy test across the globe over the forecast period.
Get a Sample PDF of This Report @ https://www.kennethresearch.com/sample-request-10008306
Global Urinalysis Test Market: Key Takeaways
- The Asia Pacific region to gain the largest portion of the revenue by 2033
- The hospitals & clinics sub-segment to dominate the revenue graph
- Pregnancy & fertility sub-segment remains prominent in the application segment
Increasing Prevalence of Diabetes around the World to Boost Market Growth
A urinalysis test refers to urine analysis. It is used to detect and treat a wide range of conditions, including urinary tract infections, kidney disease, and diabetes. The primary testing types are divided into biochemical urinalysis, pregnancy & fertility tests, sediment urinalysis, and others. More, the high prevalence of urinary infections, and diabetes is projected to boost the growth of the global urinalysis test market. According to the data by the International Diabetes Federation (IDF), in 2021, approximately 537 million adults are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Three in four adults with diabetes live in low- and middle-income countries. Hence, growing number of diabetes patients around the world is expected to be a prime factor to drive the growth of the global market.
In addition to this, increasing cases of chronic diseases across the globe is estimated to be another major factor to add to the market growth. As per the World Health Organization (WHO), chronic diseases (NCDs) kill 41 million people each year, equivalent to 71% of all deaths globally. Each year, more than 15 million people die from a chronic disease between the ages of 30 and 69 years; 85% of these premature deaths occur in low- and middle-income countries. Moreover, the rising investments in R&D activities to continuously bring up more feasible solutions for medical procedures along with the launch of new products are predicted to propel the global urinalysis test market over the projection period.
To Gain More Insights into the Global Urinalysis Test Market Analysis, Browse the Summary of the Research Report @ https://www.kennethresearch.com/report-details/urinalysis-test-market/10008306
Global Urinalysis Test Market: Regional Overview
The global urinalysis test market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa region.
Governmental Initiatives to Spread Awareness Expected to Fuel Market Growth in the Asia Pacific Region
The market in the Asia Pacific region is projected to hold the largest market share by the end of 2033 on the back of its high population base, and a rise in the cases of chronic diseases. Moreover, the role of government in spreading awareness about the tests are expected to boost the growth of the market in this region. Additionally, increasing number of CVD patients, increasing funding in healthcare infrastructure, and inactive lifestyles followed by unhealthy diets are expected to influence the growth of the urinalysis test market in the region. As per the American College of Cardiology, 58% of the total deaths caused by CVD in 2019 were reported from the Asia Pacific region.
Increasing Cardiovascular Diseases to Favor Market Growth in the North America Region
On the other hand, the market in the North America region is anticipated to witness a notable growth in the urinalysis test market on the account of extensive advancements in the healthcare infrastructure. Moreover, the high prevalence of cardiovascular disease is expected to surge the growth of the urinalysis test market in the region. As per the Centers for Disease Control and Prevention, in every 34 seconds, one person dies owing to cardiovascular disease in the U.S. Additionally, about 697,000 people in the United States died from heart disease in 2020, which was 1 in every 5 deaths. Further, the easy availability of better medical facilities, backed by the favorable medical policies are estimated to elevate the market growth in the region.
Get a Sample PDF of the Global Urinalysis Test Market @ https://www.kennethresearch.com/sample-request-10008306
The study further incorporates Y-O-Y growth, demand & supply, and forecast future opportunities in:
- North America (U.S., Canada)
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe)
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific)
- Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).
Global Urinalysis Test Market, Segmentation by End User
- Research Laboratories
- Hospitals & Clinics
- Home Care Settings
- Others
The hospitals & clinics segment is estimated to hold the largest share in the global urinalysis test market over the forecast period. The growth of this segment can be attributed to the existence of a huge patient pool in a hospital facility that requires treatment for diabetes and other chronic diseases. Moreover, rising healthcare expenditure per capita on healthcare is also estimated to propel the growth of the market. According to the data by The World Bank, as of 2019, the current health expenditure per capita among the global population was USD 1,121.97.
Access full Report Description, TOC, Table of Figures, Chart, etc. @ https://www.kennethresearch.com/sample-request-10008306
Global Urinalysis Test Market, Segmentation by Application
- Pregnancy & Fertility
- Kidney Disease
- Disease Screening
The pregnancy & fertility sub-segment is estimated to have a modest growth over the forecast period. This segmental growth can be accredited to the increasing pregnancy rates. It was noted that, as of 2019, an estimated 21 million girls aged 15–19 years in low and middle-income countries became pregnant.
Global Urinalysis Test Market, Segmentation by Testing Type
- Biochemical Urinalysis
- Pregnancy & Fertility Tests
- Sediment Urinalysis
- Others
Few of the well-known market leaders in the global urinalysis test market that are profiled by Kenneth Research are Abbott, Thermo Fisher Scientific, Bio-Rad Laboratories Inc., General Electric Company, Cardinal Health, Sysmex Corporation, F.Hoffmann-La Roche Ltd, BioMaxima SA, ACON Laboratories, Inc., Quidel Corporation, and others.
Enquiry before Buying This Report @ https://www.kennethresearch.com/sample-request-10008306
Recent Developments in the Global Urinalysis Test Market
- In January 2019, the launch of qUAntify Advance Control for use in clinical labs to do urinalysis testing was announced by Bio-Rad Laboratories Inc.
- In January 2020, Astrego Diagnostics received funding from Sysmex Corporation to create a novel urine solution for the primary care market.
Browse More Related Reports:
Global Cardiovascular Application Market Analysis by Device Type (Diagnostic & Monitoring Devices and Surgical Devices); by Application (Cardiac Arrhythmia, Coronary Artery Disease, and Heart Failure); and by End-User (Hospitals, Cardiac Care Centers, Ambulatory Centers, and Homecare & Academic Centers)-Supply & Demand Analysis & Opportunity Outlook 2023-2033
Home Healthcare Services Market Analysis by Product (Peak Flow Meters, IV Equipment, Coagulation Monitors, and Dialysis Equipment); by Type (Physician Care, Nursing Care, Occupational & Speech Therapy, Physical, Medical Social Services and Others); and by Payer (Private Health Insurance, Public Health Insurance, and Personal Savings)-Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Multiple Sclerosis Drug Market Analysis by Drug (Immunomodulators, Immunosuppressants, Interferons, and Others); by Medication Type (Oral, and Injection); by Type (Clinically Isolated Syndrome, Relapse-Remitting MS, Primary Progressive MS, and Secondary Progressive MS); by Treatment (Medications, Stem Cell Therapy, Physical Therapy, and Plasma Exchange); and by End User (Hospitals, Specialty, Clinics, Homecare, and Others)-Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Prefilled Syringes Market Analysis by Design (Single-Chamber, Dual Chamber, and Customized); by Material (Glass-Based, and Plastic Based); and by Application (Diabetes, Multiple Sclerosis, Anaphylaxis, Cancer, and Others)-Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Drug Delivery Systems Market Analysis by Type (Transdermal, Inhalation, Injectable, and Others); by Device Type (Conventional, and Advanced); by Indication (Diabetes, Cardiovascular Disease, Multiple Sclerosis, and Asthma & COPD); and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others)-Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
About Kenneth Research
Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: info@kennethresearch.com
U.S. Phone: +1 313 462 0609
Web: https://www.kennethresearch.com/
